Annexon Biosciences
About Annexon Biosciences
Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. The company’s pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune and neurodegenerative diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of innovative product candidates designed to block the activity of C1q and the entire classical complement pathway: ANX005 (intravenous administration), ANX007 (intravitreal administration), and ANX009 (subcutaneous administration). Annexon is deploying a disciplined, biomarker-driven strategy designed to improve the probability of technical success of its portfolio. For more information, visit www.annexonbio.com.
Find Annexon Biosciences Execs' Valid Emails
Up to 90% verified emails and mobile numbers, refreshed weekly.
Company Details
10M-25M
Biotechnology Research
51-200 employees
Public Company
South San Francisco, California
United States
Frequently Asked Questions about
What is Annexon Biosciences's industry?
Annexon Biosciences operates in the Biotechnology Research industry and is headquartered in United States.
How many employees does Annexon Biosciences have?
Annexon Biosciences has approximately 51-200 employees employees.
Where is Annexon Biosciences's based?
Annexon Biosciences is based in South San Francisco, California, United States.
Is Annexon Biosciences publicly listed?
Yes. Annexon Biosciences is a publicly traded company.
How can I contact Annexon Biosciences's investor relations team?
You can reach Annexon Biosciences’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.